CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.64) by 12.5 percent. This is a 40 percent decrease over losses of $(0.40) per share from
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) is advertising on Spotify, one of the world's most popular audio streaming subscription services, with over 551 million users and 220 million subscribers.